Shanghai Juntop Biosciences Co., Ltd

This early-stage study tests a new monkeypox vaccine called JT118 in 180 healthy adults aged 18 to 59. The main goal is to check if the vaccine is safe and triggers an immune response. Participants will receive one, two, or three doses and be monitored for side effects and immune…